Shandong Xinhua Pharmaceutical Co. Ltd. provided earnings guidance for the period from January 1, 2014 to June 30, 2014. Net profit attributable to the shareholders expected to be in the range of RMB 38,920,000 to­ RMB 41,420,000 compared to RMB 4,990,000 for the same period a year ago.

Basic earnings per share expected to be in the range of RMB 0.085 to RMB 0.09 compared to RMB 0.01 a year ago.